Early-stage biotech Nova Anchora has secured a new investment to move its lead therapy for epidermolysis bullosa (EB) closer ...

AstraZeneca posted a 10% rise in first-quarter revenue to $13.6 billion, supported by strong sales of cancer drugs and ...

Swiss pharma giant Novartis (NOVN: VX) this morning posted first-quarter 2025 financials, showing that net sales were $13.2 ...

The Novo Nordisk Foundation has opened its largest research funding initiative, the Challenge Programme, to applicants based outside Denmark for the first time, allowing researchers from the European ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining ...

Regeneron Pharmaceuticals (Nasdaq: REGN) today announced that the European Commission (EC) has granted conditional marketing ...

Comac Medical, a full-service contract research organization (CRO) based in Bulgaria, has announced major leadership changes ...

Belgium’s General Association of the Pharma Industry, known as pharma.de, has emphasized the importance of intellectual ...

Merck & Co has announced results from the Phase III KEYNOTE-689 trial of Keytruda (pembrolizumab) as a perioperative ...

A new category of diabetes, known as type 5 diabetes, has been officially recognized by the International Diabetes Federation ...

After reported discussions since February, German pharma and sciences company Merck KGaA (MRK: DE) has confirmed its ...